Aclaris Therapeutics, Inc. - stock earnings
ACRS Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -1.5 million USD | 17.6 million USD |
| 2023Q3 | -29.3 million USD | 9.3 million USD |
| 2023Q2 | -29.6 million USD | 1.9 million USD |
| 2023Q1 | -26.4 million USD | 2.5 million USD |
| 2022Q4 | -33.3 million USD | 7.8 million USD |
| 2022Q3 | -21.2 million USD | 19.0 million USD |
| 2022Q2 | -16.7 million USD | 1.5 million USD |
| 2022Q1 | -17.5 million USD | 1.5 million USD |
| 2021Q4 | -22.8 million USD | 1.5 million USD |
| 2021Q3 | -21.1 million USD | 1.7 million USD |
| 2021Q2 | -18.2 million USD | 1.8 million USD |
| 2021Q1 | -28.8 million USD | 1.8 million USD |
| 2020Q4 | -13.2 million USD | 1.6 million USD |
| 2020Q3 | -10.7 million USD | 1.4 million USD |
| 2020Q2 | -11.6 million USD | 2.0 million USD |
| 2020Q1 | -15.6 million USD | 1.4 million USD |
| 2019Q4 | -18.6 million USD | 1.1 million USD |
| 2019Q3 | -55.3 million USD | 983000 USD |
| 2019Q2 | -49.9 million USD | 5.9 million USD |
| 2019Q1 | -37.6 million USD | 5.0 million USD |
| 2018Q4 | -38.6 million USD | 3.7 million USD |
| 2018Q3 | -32.7 million USD | 1.6 million USD |
| 2018Q2 | -31.2 million USD | 3.7 million USD |
| 2018Q1 | -30.2 million USD | 1.1 million USD |
| 2017Q4 | -22.9 million USD | 999000 USD |
| 2017Q3 | -18.2 million USD | 684000 USD |
| 2017Q2 | -14.8 million USD | ? USD |
| 2017Q1 | -12.6 million USD | ? USD |
| 2016Q4 | -11.5 million USD | ? USD |
| 2016Q3 | -10.7 million USD | ? USD |
| 2016Q2 | -12.9 million USD | ? USD |
| 2016Q1 | -13.0 million USD | ? USD |
| 2015Q4 | -4.7 million USD | ? USD |
| 2015Q3 | -10.6 million USD | ? USD |
| 2015Q2 | -2.6 million USD | ? USD |
| 2015Q1 | -2.6 million USD | ? USD |
| 2014Q4 | -2.6 million USD | ? USD |
| 2014Q3 | -2.7 million USD | ? USD |
ACRS Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -88.5 million USD | 31.2 million USD |
| 2022 | -88.7 million USD | 29.8 million USD |
| 2021 | -114.3 million USD | 6.8 million USD |
| 2020 | -51.2 million USD | 6.5 million USD |
| 2019 | -142.9 million USD | 4.2 million USD |
| 2018 | -132.7 million USD | 10.1 million USD |
| 2017 | -68.5 million USD | 1.7 million USD |
| 2016 | -48.1 million USD | ? USD |
| 2015 | -20.6 million USD | ? USD |
| 2014 | -8.5 million USD | ? USD |
| 2013 | -5.2 million USD | ? USD |
ACRS
Price: $1.36
52 week price:
Earnings Per Share: -1.27 USD
P/E Ratio: -0.74
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 2.0 million
Ebitda: -18.6 millionMarket Capitalization: 88.1 million